DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Levorphanol Tartrate is a drug marketed by Novitium Pharma, Sentynl Theraps Inc, Specgx Llc, and Virtus Pharms. and is included in four NDAs.
The generic ingredient in LEVORPHANOL TARTRATE is levorphanol tartrate. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
A generic version of LEVORPHANOL TARTRATE was approved as levorphanol tartrate by SENTYNL THERAPS INC on March 31st, 2000.